Fibrotic effects and regulation of MMP proteins in thrombus resolution
Fibrotic effects and regulation of MMP proteins in thrombus resolution
批准号:
7392800
负责人:
RAJABRATA SARKAR
金额:
$40.05万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-12 至 2010-03-31
关键词:
Adenovirus VectorAffectAmericanBiological AssayBiomechanicsBlood ClotBlood VesselsBlood coagulationChronicCicatrixCoagulation ProcessCollagenDeep Vein ThrombosisDevelopmentDisease regressionElasticityEnd PointEndopeptidasesEndothelial CellsEnzymesEssential GenesEventFibrosisFunctional disorderGelatinase AGelatinase BGenesGenetic TranscriptionHumanInterstitial CollagenaseKnowledgeLeadLegLocalizedMatrix MetalloproteinasesMetalloproteinase GeneMolecularMusObstructionPainPain in lower limbPathogenesisPatientsPatternPeptide HydrolasesPlayPostphlebitic SyndromeProcessProtein IsoformsProtein OverexpressionProteinsRegulationReporterResearch PersonnelResearch ProposalsResolutionRoleSeriesSkinSmooth Muscle MyocytesSwellingTestingThrombophlebitisThrombusTissuesTransgenic OrganismsUlcerVeinsVenousactivating transcription factorcell motilitycell typechromatin immunoprecipitationclinically significanthuman MMP14 proteinmonocytemouse modelnovelpreventprogramsresearch studytranscription factor
中文摘要
深静脉血栓形成(DVT)每年影响超过200万美国人。静脉炎后综合征
可影响25-75%的DVT患者,包括腿部肿胀、疼痛、皮肤变化和溃疡。
皮肤这仅发生在DVT患者的一个子集中,表明血栓消退在DVT患者中至关重要。
确定慢性静脉阻塞和纤维化是否会发展并导致静脉炎后
综合征基质金属蛋白酶(MMP)基因对细胞迁移和组织重塑至关重要,
在血栓消退过程中表达和激活,表明在该过程中起关键作用。农村妇女在消除
静脉炎后综合征的发病机制将被定义为三个特定的目的:1)定义静脉炎后综合征的发病机制,
MMP-2基因的区域和对血栓诱导的MMP-2至关重要的同源转录因子
MMP-2、MMP-9和MMP-14(MT-MMP-f)在DVT消退中的作用,
3)检测血栓诱导的静脉壁纤维化中MMP蛋白(MMP-2、MMP-9)的过度表达,
和MMP-14)加速DVT消退并改变血栓诱导的静脉壁纤维化。一系列独特的
将使用转基因MMP-2报告小鼠来确定MMP-2基因的哪些区域是必需的
血栓诱导的MMP-2转录和染色质免疫沉淀将用于鉴定
同源转录因子。将使用具有各种MMP基因的靶向缺失的小鼠来确定
这些酶在血栓再通、静脉壁纤维化和静脉壁顺应性丧失中的作用,
使用小鼠静脉生物力学的新测定来研究弹性。
MMP-2、MMP-14和MMP-9以及编码这些同种型的腺病毒载体将用于过表达
这些蛋白质在血栓消退过程中,以确定DVT的消退是否加速,
这些研究将确定MMP蛋白在血管壁生物力学中的作用,
血栓溶解的有害方面,并表征潜在的分子治疗,以防止后
静脉炎综合征
相关性:该提案将确定基质金属蛋白酶蛋白如何引起瘢痕形成,
血栓形成后静脉增厚,这可能会导致以后的腿部疼痛,肿胀和溃疡。这些研究将
增加静脉如何被血栓破坏的知识,并测试新的治疗方法来防止这种损害。
英文摘要
Deep venous thrombosis (DVT) affects more than 2 million Americans per year. Post-phlebitic syndrome
can affect 25-75% of patients following DVT and includes leg swelling, pain, skin changes and ulceration of
the skin. This develops only in a subset of DVT patients, suggesting that thrombus resolution is critical in
determining whether chronic venous obstruction and fibrosis will develop and lead to post-phlebitic
syndrome. Matrix metalloproteinase (MMP) genes, critical to cell migration and tissue remodeling, are
expressed and activated during thrombus resolution suggesting a critical role in this process. Their role in
the pathogenesis of post-phlebitic syndrome will be defined with three Specific Aims: 1) To define the
regions of the MMP-2 gene and cognate transcription factors critical to thrombus-induced MMP-2
expression, 2) To determine the role of MMP-2, MMP-9 and MMP-14 (MT-MMP-f) in DVT resolution and
thrombus-induced vein wall fibrosis, 3) To determine if overexpression of MMP proteins (MMP-2, MMP-9
and MMP-14) accelerates DVT resolution and alters thrombus-induced vein wall fibrosis. A unique series of
transgenic MMP-2 reporter mice will be used to determine which regions of the MMP-2 gene are essential
for thrombus-induced MMP-2 transcription and chromatin immunoprecipitation will be used to identity the
cognate transcription factors. Mice with targeted deletion of various MMP genes will be used to determine
the role of these enzymes in thrombus recanalization, vein wall fibrosis and loss of vein wall compliance and
elasticity using novel assays of mouse vein biomechanics.Tissue-specific transgenic overexpression of
MMP-2, -14 and -9 as well as adenoviral vectors encoding these isoforms will be utilized to overexpress
these proteins during thrombus resolution to determine resolution of DVT is accelerated and the effects on
fibrosis and vein wall biomechanics.These studies will define the role of MMP proteins in the beneficial and
detrimental aspects of thrombus resolution, and characterize potential molecular therapy to prevent post-
phlebitic syndrome.
RELEVANCE: This proposalwill determine how matrix metalloproteinase proteins cause scarring and
thickening of veins after blood clots, which can cause later leg pain, swelling and ulcers. These studies will
increase knowledge of how veins are damaged by clots and test new treatments to prevent this damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The effect of Myristolated alanine-rich C Kinase Substrate (MARCKS) on kinase interacting with stathmin (KIS) in differential proliferation of vascular smooth muscle and endothelial cells
-
批准号:10198997
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2017
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7071000
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7613397
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7236604
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7464343
-
项目类别:
-
资助金额:$8.83万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7032907
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7179336
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Fibrotic effects and regulation of MMP proteins in thrombus resolution
-
批准号:7996428
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7365275
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
Mechanisms of MMP-2 transcription in hindlimb ischemia
-
批准号:7790670
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2006
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6189900
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6619798
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6388687
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6526591
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
NITRIC OXIDE AND SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6779743
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2000
-
负责人:RAJABRATA SARKAR
-
依托单位:
EFFECT OF RECOMBINANT TPA GENE EXPRESSION IN ENDOTHELIUM
-
批准号:2213453
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1994
-
负责人:RAJABRATA SARKAR
-
依托单位:
EFFECT OF RECOMBINANT TPA GENE EXPRESSION IN ENDOTHELIUM
-
批准号:3052057
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1992
-
负责人:RAJABRATA SARKAR
-
依托单位:
海外基金